SmarTTransfuser - A Biochip System for the Final ABO Compatibility Test

Karine Charrière, Jean Sebastien Guerrini-Chappuis, Bruno Wacogne, Alain Rouleau, Celine Elie-Caille, Christian Pieralli, Lionel Pazart, Pascal Morel, Wilfrid Boireau

Abstract

Before each transfusion of red blood cell concentrate, a final ABO compatibility test is carried out at the patient's bedside on a piece of card and interpreted visually. Despite this ultimate test, transfusion accidents still occur due to group incompatibility, which can be lethal. In order to improve this test, we have developed a specific device based on microarrays for the validation of a smart and safe transfuser in the context of critical transfusional situations. This miniaturized device incorporates a biochip to analyze ABO compatibility in order that the hemagglutination reaction of red blood cells with IgMs in solution be replaced by specific capture and concentration of IgMs on microarrays. Results indicate that a specific immunocapture is obtained with globular concentrates and with different total blood. Smarttransfuser is a smart device developed in collaboration with the French Blood Transfusion Center for the optimization at the patient’s bedside of an ultimate test prior to transfusion.

References

  1. Aandahl, G. S., Knutsen, T. R., Nafstad, K., 2007. Implementation of ISBT 128, a quality system, a standardized bar code labeling of blood products worldwide, electronic transfusion pathway: four years of experience in Norway. Transfusion, 47(9), p.1674- 1678.
  2. Afssaps, 2010. Rapport annuel hémovigilance. Available at: http://www.afssaps.fr/.
  3. Afssaps, 2004. Rapport annuel hémovigilance. Available at: http://www.afssaps.fr/
  4. Boireau, W. et al., 2009. Revisited BIA-MS combination: entire «on-a-chip» processing leading to the proteins identification at low femtomole to sub-femtomole levels. Biosensors & Bioelectronics, 24(5), p.1121- 1127.
  5. British Committee for Standards in Haematology, 2009. Guideline on the Administration of Blood Components. Available at: http://www.bcshguidelines. com/documents/Admin_blood_components_bcsh_050 12010.pdf.
  6. Dzik, W. H., 2007. New technology for transfusion safety. British Journal of Haematology, 136(2), p.181-190.
  7. Dzik, W. H., 2005. Technology for enhanced transfusion safety. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, p.476-482.
  8. FDA, 2010. Fatalities Reported to FDA Following Blood Collection and Transfusion. Available at: http://www. fda.gov/downloads/BiologicsBloodVaccines/SafetyAv ailability/ReportaProblem/TransfusionDonationFataliti es/UCM254860.pdf.
  9. Levy, G., 2008. [The pretransfusion bedside agglutination test is not a «Gold Standard»]. Transfusion Clinique Et Biologique: Journal De La Société Française De Transfusion Sanguine, 15(5), p.318-321.
  10. National Blood Collection and Utilization Survey, 2009. The 2009 national blood collection and utilization survey report. Available at: http://www.aabb.org/pro grams/biovigilance/nbcus/Documents/09-nbcus-report.
  11. Pazart L., Wacogne B., Pieralli C., Boireau W., Morel P., "Secure perfusion system", Patent WO 2011055031.
  12. Pazart L., Wacogne B., Pieralli C., Boireau W., Morel P., "Device for taking a sample of a body fluid and method for implementing same", Patent WO 2011055029.
  13. SHOT, 2009. Annual Report. Available at: http://www. shotuk.org/
  14. Stainsby, D., 2005. ABO incompatible transfusions-- experience from the UK Serious Hazards of Transfusion (SHOT) scheme Transfusions ABO incompatible. Transfusion Clinique Et Biologique: Journal De La Société Française De Transfusion Sanguine, 12(5), p.385-388.
  15. Stenberg, E., 1991. Quantitative determination of surface concentration of protein with surface plasmon resonance using radiolabeled proteins. Journal of Colloid and Interface Science, 143(2), p.513-526.
Download


Paper Citation


in Harvard Style

Charrière K., Sebastien Guerrini-Chappuis J., Wacogne B., Rouleau A., Elie-Caille C., Pieralli C., Pazart L., Morel P. and Boireau W. (2012). SmarTTransfuser - A Biochip System for the Final ABO Compatibility Test . In Proceedings of the International Conference on Biomedical Electronics and Devices - Volume 1: BIODEVICES, (BIOSTEC 2012) ISBN 978-989-8425-91-1, pages 257-262. DOI: 10.5220/0003852402570262


in Bibtex Style

@conference{biodevices12,
author={Karine Charrière and Jean Sebastien Guerrini-Chappuis and Bruno Wacogne and Alain Rouleau and Celine Elie-Caille and Christian Pieralli and Lionel Pazart and Pascal Morel and Wilfrid Boireau},
title={SmarTTransfuser - A Biochip System for the Final ABO Compatibility Test},
booktitle={Proceedings of the International Conference on Biomedical Electronics and Devices - Volume 1: BIODEVICES, (BIOSTEC 2012)},
year={2012},
pages={257-262},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0003852402570262},
isbn={978-989-8425-91-1},
}


in EndNote Style

TY - CONF
JO - Proceedings of the International Conference on Biomedical Electronics and Devices - Volume 1: BIODEVICES, (BIOSTEC 2012)
TI - SmarTTransfuser - A Biochip System for the Final ABO Compatibility Test
SN - 978-989-8425-91-1
AU - Charrière K.
AU - Sebastien Guerrini-Chappuis J.
AU - Wacogne B.
AU - Rouleau A.
AU - Elie-Caille C.
AU - Pieralli C.
AU - Pazart L.
AU - Morel P.
AU - Boireau W.
PY - 2012
SP - 257
EP - 262
DO - 10.5220/0003852402570262